Edizioni

Rivista e Edizione

AHEAD OF PRINT

Volume 11 (2021): Edizione 2 (December 2021)

Volume 11 (2021): Edizione 1 (December 2021)

Volume 10 (2020): Edizione 1 (December 2020)

Volume 9 (2019): Edizione 2 (December 2019)

Volume 9 (2019): Edizione 1 (December 2019)

Volume 8 (2018): Edizione 2 (December 2018)

Volume 8 (2018): Edizione 1 (June 2018)

Volume 7 (2017): Edizione 2 (December 2017)

Volume 7 (2017): Edizione 1 (June 2017)

Volume 6 (2016): Edizione 2 (December 2016)

Volume 6 (2016): Edizione 1 (June 2016)

Volume 5 (2015): Edizione 2 (December 2015)

Volume 5 (2016): Edizione 1 (June 2016)

Volume 4 (2014): Edizione 2 (December 2014)

Volume 4 (2014): Edizione 1 (June 2014)

Volume 3 (2013): Edizione 2 (December 2013)

Volume 3 (2013): Edizione 1 (June 2013)

Volume 2 (2012): Edizione 2 (December 2012)

Volume 2 (2012): Edizione 1 (June 2012)

Volume 1 (2011): Edizione 2 (December 2011)

Volume 1 (2011): Edizione 1 (June 2011)

Dettagli della rivista
Formato
Rivista
eISSN
2084-1264
Pubblicato per la prima volta
09 Apr 2014
Periodo di pubblicazione
2 volte all'anno
Lingue
Inglese

Cerca

AHEAD OF PRINT

Dettagli della rivista
Formato
Rivista
eISSN
2084-1264
Pubblicato per la prima volta
09 Apr 2014
Periodo di pubblicazione
2 volte all'anno
Lingue
Inglese

Cerca

2 Articoli
Accesso libero

When Science Races: the Standard of Care and Medical Negligence in the Times of Covid-19

Pubblicato online: 28 Sep 2022
Pagine: -

Astratto

Abstract

When a new disease emerges, there are at first no specific medicinal products to treat it. This has also been the case in the Covid-19 pandemic. Scientists and health professionals have been trying to establish the best treatments possible using the already-existing medicines that are normally used for different indications. The off-label use of medicinal products is a standard part of medical practice. If it meets certain criteria, it is not contradictory to the standard of care. Nevertheless, the urgency of the pandemic situation brings about new issues. What amount of data on efficacy and safety should be considered sufficient to scientifically justify the off-label use of a particular medicine? How should health professionals reflect the rapid scientific developments and high levels of uncertainty in their clinical practice? How can be these factors influenced by the politicisation of medicine? The paper deals with the outlined questions in order to analyse and concretise the criteria for off-label use of medicinal product in the specific context of the Covid-19 pandemic.

Parole chiave

  • health law
  • standard of care
  • medical negligence
  • off-label use of medicinal products
  • Covid-19
  • tort law
Accesso libero

Medical Liability for Allocation of Scarce Healthcare Resources in the COVID-19 Pandemic: the Italian scenario

Pubblicato online: 05 Jan 2023
Pagine: -

Astratto

Abstract Summary

1. Tragic Choices in COVID times; 2. Criteria for the Allocation of Scarce Healthcare Resources; 3. Liability of Healthcare Professionals and Institutions; 4. Possible solutions?

Parole chiave

  • Medical liability
  • covid-19
  • resource allocation
2 Articoli
Accesso libero

When Science Races: the Standard of Care and Medical Negligence in the Times of Covid-19

Pubblicato online: 28 Sep 2022
Pagine: -

Astratto

Abstract

When a new disease emerges, there are at first no specific medicinal products to treat it. This has also been the case in the Covid-19 pandemic. Scientists and health professionals have been trying to establish the best treatments possible using the already-existing medicines that are normally used for different indications. The off-label use of medicinal products is a standard part of medical practice. If it meets certain criteria, it is not contradictory to the standard of care. Nevertheless, the urgency of the pandemic situation brings about new issues. What amount of data on efficacy and safety should be considered sufficient to scientifically justify the off-label use of a particular medicine? How should health professionals reflect the rapid scientific developments and high levels of uncertainty in their clinical practice? How can be these factors influenced by the politicisation of medicine? The paper deals with the outlined questions in order to analyse and concretise the criteria for off-label use of medicinal product in the specific context of the Covid-19 pandemic.

Parole chiave

  • health law
  • standard of care
  • medical negligence
  • off-label use of medicinal products
  • Covid-19
  • tort law
Accesso libero

Medical Liability for Allocation of Scarce Healthcare Resources in the COVID-19 Pandemic: the Italian scenario

Pubblicato online: 05 Jan 2023
Pagine: -

Astratto

Abstract Summary

1. Tragic Choices in COVID times; 2. Criteria for the Allocation of Scarce Healthcare Resources; 3. Liability of Healthcare Professionals and Institutions; 4. Possible solutions?

Parole chiave

  • Medical liability
  • covid-19
  • resource allocation

Pianifica la tua conferenza remota con Sciendo